Tests brain stimulation of the cerebellum in young adults with autism
Tests cerebellum stimulation on social and planning skills in young adults with autism.
Plain-language title generated from the registry record
Registry title: Cerebellum and Autism: Regional Specialization for Social and Executive Functions
Key facts
- Where
- Washington D.C., United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 35 years old?
Source: NCT05396352, who can take part
Where in United States
- American UniversityWashington D.C., United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- American University
- Trial code
- NCT05396352
- Record updated
- 2 October 2025
- Original description
The goal of this study is to determine the impact of neuromodulation to the cerebellum on social and executive functions in neurotypical young adults and young adults with autism.Read full original descriptionShow less
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
The goal of this study is to determine the impact of neuromodulation to the cerebellum on social and executive functions in neurotypical young adults and young adults with autism.
Inclusion: All participants; Aged 18-35; Able to provide written, informed consent; NIH Toolbox age-adjusted Cognitive Function Composite standard score ≥ 85; Native English speaker; Right-handed; Not pregnant; Able to attend all study sessions; Pass safety screening for MRI and neuromodulation (e.g. no metal in body, implanted devices, history of seizure, claustrophobia); Additional INCLUSION criteria for adults with autism Either; Prior research-reliable diagnosis of autism spectrum disorder (ASD) Or; Meet DSM-5 criteria for ASD confirmed with ADOS-2 via research-reliable clinical assessment.
Exclusion: Current or prior history of neurological or neurodevelopmental condition or brain injury; Psychotropic medication; Contraindications for MRI or neuromodulation with tDCS (e.g. metal in body, pacemaker or other implanted device, history of seizure, claustrophobia); Contraindications for MRI or neuromodulation with tDCS (e.g. metal in body, pacemaker or other implanted device, history of seizure, claustrophobia); Age <18 or >35; NIH Toolbox age-adjusted Cognitive Function Composite standard score < 85; Age <18 or >35; NIH Toolbox age-adjusted Cognitive Function Composite standard score < 85; Neurotypical adults; Pregnancy; Adults with autism; Participants with a legal authorized representative; Pregnancy.
Please note: This study takes place at American University and Georgetown University in Washington, DC. We do not have funds for travel and lodging available for this study, so participants should be local to the DC region.